News | November 05, 2024
Lonza’s Synaffix collaborates with BigHat Biosciences for ML-designed ADC
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
The OPTASE range is a safe, tested and expert recommended 3-step regime to help tackle the cause and symptoms of eye conditions
Coupled with Shea Butter, Cocoa Butter, and Mango Butter, the balm provides deep hydration, ensuring lips remain soft, smooth, and well-moisturized throughout the day
The company reported total income at Rs. 509.8 crore in Q1 FY25 as compared to Rs. 570.3 crore in Q1 FY24
Observes no adverse impact of non-nutritive sweetener (NNS) - sucralose on glycemic markers
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
Dyslipidemia is a critical risk factor for cardiovascular diseases
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
The receipt of this permission paves way for the launch of BREZTRI AEROSPHERE in India
Subscribe To Our Newsletter & Stay Updated
